Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

NCT00001644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Indinavir
DRUG: Zidovudine
DRUG: Lamivudine
DRUG: Nevirapine
PROCEDURE: Blood testing
PROCEDURE: Lymph node biospy
PROCEDURE: Leukapheresis

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)